TAXIMED Injection 1gr
Family: Third-Generation Cephalosporin Antibiotic.
Active Ingredient: Cefotaxime Sodium 1 g.
Indications: TAXIMED is indicated for the treatment of susceptible bacterial infections, including respiratory tract infections, urinary tract infections, skin and soft-tissue infections, bone and joint infections, septicemia, and meningitis, according to approved prescribing information.
Clinical Benefits: Cefotaxime inhibits bacterial cell-wall synthesis, producing bactericidal activity against susceptible bacteria. Its broad-spectrum antibacterial activity supports the treatment of selected infections requiring injectable antibiotic therapy.
Key Benefits: Offers effective antibacterial activity against a range of susceptible Gram-positive and Gram-negative organisms. Its injectable formulation provides a treatment option for patients who require parenteral antibiotic therapy under medical supervision.
Dosage and Administration: The dose, route, frequency, and duration of treatment depend on the infection, patient age, severity of illness, renal function, and clinical response. TARXIMED should be administered by a qualified healthcare professional according to the approved product information.
Possible Adverse Effects: Possible adverse effects include injection-site pain, diarrhea, nausea, skin rash, allergic reactions, and changes in liver enzymes or blood-cell counts. Rare but serious complications may include severe hypersensitivity reactions and antibiotic-associated colitis.
Important Information: Use only for appropriate bacterial infections. Check for a history of allergy to cephalosporins or other beta-lactam antibiotics. Dosage adjustment may be necessary in patients with impaired renal function.
Company: INTERMED